Mak Duncan H F, Chiu P Y, Dong Tina T X, Tsim Karl W K, Ko K M
Department of Biochemistry, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.
Phytother Res. 2006 Jul;20(7):561-7. doi: 10.1002/ptr.1904.
The effects of pretreatment with Dang-Gui Buxue Tang (DBT, a decoction of Astragali and Angelica roots) and its component herb extracts on myocardial ischaemia-reperfusion (IR) injury were examined in rats ex vivo. DBT and its component herb extracts could protect against myocardial IR injury in a dose-dependent manner. The more potent cardioprotection afforded by DBT pretreatment than that of a mixture of Astragali and Angelica root extracts was associated with a much higher extraction yield of active ingredients from Angelica root in the herbal decoction. The high level of active ingredients might increase their bioavailability after oral administration. DBT pretreatment could enhance myocardial mitochondrial as well as red blood cell (RBC) glutathione status, thereby increasing their resistance to oxidative stress-induced injury in rats. The measurement of RBC glutathione status may serve as a useful index for the antioxidant effect produced by DBT treatment in human subjects.
在大鼠离体实验中,研究了当归补血汤(DBT,黄芪和当归根的水煎剂)及其单味药提取物预处理对心肌缺血再灌注(IR)损伤的影响。DBT及其单味药提取物能以剂量依赖的方式保护心肌免受IR损伤。与黄芪和当归根提取物混合物相比,DBT预处理具有更强的心脏保护作用,这与该中药汤剂中当归根活性成分的提取率更高有关。活性成分的高含量可能会增加其口服后的生物利用度。DBT预处理可增强心肌线粒体以及红细胞(RBC)的谷胱甘肽状态,从而提高大鼠对氧化应激诱导损伤的抵抗力。测量RBC谷胱甘肽状态可能是DBT治疗对人体产生抗氧化作用的有用指标。